During the past decade, Kurmitola General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kurmitola General Hospital" #1 collaborator was "Bangladesh Reference Institute of Chemical Measurements (BRICM)" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kurmitola General Hospital" are "COVID-19 Pneumonia" (1 trials), "Effect of Drug" (1 trials), "Efficacy, Self" (1 trials), "Lung Cancer" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Kurmitola General Hospital" in a lesser frequency.

Most popular intervention types in "Kurmitola General Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.6% PVP-I Oral and nasal spray to asymptomatic to mild COVID-19 patient having multiple comorbidity" (1 trials), "0.6% PVP-I Oral and nasal spray to healthy volunteer" (1 trials), "0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient" (1 trials), "Baricitinib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kurmitola General Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kurmitola General Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kurmitola General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kurmitola General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".